Theravance (THRX)

Theravance (THRX) Q3 2015 Results - Earnings Call Webcast
Oct. 28, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Michael Aguiar on Q3 2015 Results - Earnings Call Transcript
Oct. 28, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Michael Aguiar on Q2 2015 Results - Earnings Call Transcript
July 29, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q1 2015 Results - Earnings Call Transcript
May 6, 2015 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q1 2015 Results - Earnings Call Webcast
May 6, 2015 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q4 2014 Results - Earnings Call Webcast
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q4 2014 Results - Earnings Call Transcript
Feb. 18, 2015 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Credit Suisse Healthcare Conference - Call Transcript
Nov. 13, 2014 | Price: Free! | Source: Seeking Alpha

Theravance (THRX) Q3 2014 Results - Earnings Call Webcast
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Mike Aguiar on Q3 2014 Results - Earnings Call Transcript
Oct. 30, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q2 2014 Results - Earnings Call Transcript
Aug. 7, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham Hosts 2014 Annual Meeting of Stockholders Conference
May 22, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Bank of America Merrill Lynch 2014 Health Care Conferenc
May 13, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's (THRX) CEO Rick Winningham on Q1 2014 Results - Earnings Call Transcript
May 6, 2014 | Price: Free! | Source: Seeking Alpha

Q1 2014 Theravance Inc Earnings Conference Call (THRX) Q1 2014 Results - Earnings Call Webcast
May 6, 2014 | Price: Free! | Source: Seeking Alpha

Theravance Announces Positive Results From a Phase 2 Study of TD-9855 in Patients With Fibromyalgia
May 1, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Presents at Barclays Global Healthcare Conference (Transcript)
March 11, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2013 Results - Earnings Call Transcript
Feb. 7, 2014 | Price: Free! | Source: Seeking Alpha

Q4 2013 Theravance Inc Earnings Conference call (Webcast)
Feb. 7, 2014 | Price: Free! | Source: Seeking Alpha

Theravance's Management Presents at 32nd Annual JPMorgan Healthcare Conference (Transcript)
Jan. 16, 2014 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Piper Jaffray Healthcare Conference Transcript
Dec. 3, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Credit Suisse Healthcare Conference Transcript
Nov. 13, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Presents at Credit Suisse Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Theravance Inc's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 24, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q3 2013 Earnings Conference Call Transcript
Oct. 24, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Stifel Nicolaus Weisel Healthcare Conference Transcript
Sept. 12, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Robert W Baird and Co Health Care Conference Transcript
Sept. 11, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Reviews Phase 2b Study 0091 with its LAMA Candidate TD-4208 Results - Transcript
Sept. 5, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Conference Call to Discuss Positive Results From TD-4208 for the Treatment of COPD S
Sept. 5, 2013 | Price: $106.00 | Source: Thomson

Theravance Inc (THRX) CEO Discusses Q2 2013 Results - Earnings Call Transcript
July 25, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q2 2013 Earnings Conference Call Transcript
July 25, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at JMP Securities Healthcare Conference Transcript
July 10, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at JMP Securities Healthcare Conference Transcript
July 10, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Goldman Sachs Healthcare Conference Transcript
June 13, 2013 | Price: $106.00 | Source: Thomson

Theravance's Management Presents at Goldman Sachs Healthcare Conference (Transcript)
June 13, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Jefferies Global Healthcare Conference Transcript
June 5, 2013 | Price: $106.00 | Source: Thomson

THERAVANCE INC at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript)
May 15, 2013 | Price: Free! | Source: Seeking Alpha

Theravance and Elan Enter Into a 1 Billion Dollar Royalty Participation Agreement (Transcript)
May 13, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q1 2013 Results - Earnings Call Transcript
April 25, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q1 2013 Earnings Conference Call Transcript
April 25, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Hosts 2013 Annual Meeting of Stockholders Conference (Transcript)
April 24, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at Barclays Healthcare Conference Transcript
March 14, 2013 | Price: $54.00 | Source: Thomson

Theravance Management Presents at Barclays 2013 Global Healthcare Conference (Transcript)
March 14, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Presents at 2013 Citi Global Healthcare Conference (Transcript)
Feb. 27, 2013 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Feb. 13, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q4 2012 Earnings Conference Call Transcript
Feb. 12, 2013 | Price: $106.00 | Source: Thomson

Theravance's CEO Presents at J.P. Morgan Global Healthcare Conference (Transcript)
Jan. 9, 2013 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC at JPMorgan Global Healthcare Conference Transcript
Jan. 9, 2013 | Price: $54.00 | Source: Thomson

Theravance's Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Nov. 14, 2012 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Oct. 30, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q3 2012 Earnings Conference Call Transcript
Oct. 30, 2012 | Price: $106.00 | Source: Thomson

Theravance's Management Present at Morgan Stanley Global Healthcare Conference (Transcript)
Sept. 12, 2012 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript
July 31, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC Q2 2012 Earnings Conference Call Transcript
July 31, 2012 | Price: $54.00 | Source: Thomson

Theravance's CEO Announces Positive Topline Results From TD-1211 Phase 2b Study 0084 for the Treatm
July 12, 2012 | Price: Free! | Source: Seeking Alpha

Theravance's CEO Discusses LAMA/LABA Phase 3a Results Conference Call (Transcript)
July 2, 2012 | Price: Free! | Source: Seeking Alpha

THERAVANCE INC GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for
July 2, 2012 | Price: $54.00 | Source: Thomson

THERAVANCE INC at Bank of America Merrill Lynch Smid Cap Conference Transcript
June 7, 2012 | Price: $54.00 | Source: Thomson

THERAVANCE INC Q1 2012 Earnings Conference Call Transcript
April 26, 2012 | Price: $54.00 | Source: Thomson

Theravance, Inc.(THRX) Q1 2012 Earnings Call Transcript
April 26, 2012 | Price: Free! | Source: Morningstar

Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call Transcript
Oct. 21, 2010 | Price: Free! | Source: Seeking Alpha

Theravance Inc Q2 2010 Earnings Call Transcript
July 22, 2010 | Price: Free! | Source: Seeking Alpha

Theravance Inc. Q1 2010 Earnings Call Transcript
April 21, 2010 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q3 2009 Earnings Call Transcript
Oct. 27, 2009 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q4 2008 Earnings Call Transcript
Feb. 12, 2009 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q3 2008 Earnings Call Transcript
Oct. 29, 2008 | Price: Free! | Source: Seeking Alpha

Theravance, Inc. Q2 2008 Earnings Call Transcript
Aug. 11, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Theravance's Chief Accounting Officer just disposed of 1,129 shares - Aug. 24, 2021

Theravance's Chief Accounting Officer just disposed of 2,433 shares - Aug. 23, 2021

Theravance Just Filed Its Quarterly Report: 2. Net Income Per Sh... - July 29, 2021

Theravance: Innoviva Reports Second Quarter 2021 Financial Results - July 28, 2021

Major owner of Theravance just picked up 6,268,975 shares - June 11, 2021

Statement of acquisition of beneficial ownership by individuals - June 7, 2021

Current report, item 1.01 - May 26, 2021

General statement of acquisition of beneficial ownership - May 25, 2021

Statement of changes in beneficial ownership of securities - May 25, 2021

Theravance director just picked up 20,000 shares - May 25, 2021

General statement of acquisition of beneficial ownership - May 25, 2021

Theravance's Chief Accounting Officer just disposed of 759 shares - May 24, 2021

Statement of changes in beneficial ownership of securities - May 24, 2021

Major owner of Theravance just picked up 3,731,025 shares - May 20, 2021

Current report, items 1.01, 8.01, and 9.01 - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Theravance director just picked up 17,482 shares - May 20, 2021

Submission of Matters to a Vote of Security - May 20, 2021

Statement of changes in beneficial ownership of securities - May 20, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - May 5, 2021

General statement of acquisition of beneficial ownership - May 3, 2021

General statement of acquisition of beneficial ownership - April 5, 2021

Other definitive proxy statements - April 2, 2021

Theravance director just picked up 1,612 shares - March 30, 2021

Theravance's Chief Accounting Officer just picked up 10,305 shares - March 30, 2021

Theravance director was just granted 10,748 restricted shares - March 24, 2021

Major owner of Theravance just picked up 4,285,935 shares - March 17, 2021

Innoviva Strategic Opportunities LLC just provided an update on activist position in Theravance - March 17, 2021

Theravance director just declared 0 ownership of the company. - March 16, 2021

Departure of Directors or Principal - March 10, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - Feb. 25, 2021

Theravance's Chief Accounting Officer just disposed of 2,108 shares - Feb. 22, 2021

Renaissance Technologies LLC just provided an update on share ownership of Theravance - Feb. 11, 2021

The Vanguard Group just provided an update on share ownership of Theravance - Feb. 10, 2021

Theravance: Innoviva Reports Fourth Quarter 2020 Financial Results - Feb. 3, 2021

Major owner of Theravance just picked up 1,867,912 shares - Jan. 28, 2021

Innoviva Strategic Opportunities LLC just provided an update on activist position in Theravance - Jan. 27, 2021

BlackRock, Inc. just provided an update on share ownership of Theravance - Jan. 27, 2021

Entry into a Material Definitive Agreement - Dec. 14, 2020

Sarissa Capital Master Fund II LP just provided an update on activist position in Theravance - Dec. 14, 2020

Sorry, no schedule available for this company

 


Feedback